Delivery Order SPE2DB20D1100-SPE2DB25FE5Z8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,356.57 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Docetaxel 160 mg/16 ml vials. This award represents a firm fixed-price delivery order with an ultimate completion date of July 31, 2025, and carries no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,097.08 to AmerisourceBergen Drug Corp for the supply of Docetaxel 80 mg/4 mL vials. The contract was awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, and carries firm fixed pricing with no set-aside designation. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Docetaxel 80 mg/4 mL vials valued at $1,093.69. This is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and represents a non-set-aside competitive award. The products will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $4,041.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Docetaxel 160 mg/16 ml vials on September 4, 2025, with an ultimate completion date of September 5, 2025. This non-competitive set-aside delivery order represents a pharmaceutical supply transaction fulfilling military healthcare requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,574.73 for Docetaxel 160 mg/16 mL vials on September 3, 2025, with an ultimate completion date of September 4, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Docetaxel is a chemotherapy medication used primarily in cancer treatment protocols across military and federal...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,916.80, is for the delivery of Docetaxel 160 mg/16 ml vials. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 3, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $8,649.54 firm fixed price delivery order to AmerisourceBergen Drug Corp for Paclitaxel Protein-Bound 100mg on September 3, 2025, with an ultimate completion date of September 4, 2025. This non-set-aside delivery order is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under the vendor's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive...
- The Defense Logistics Agency awarded a delivery order valued at $4,467.19 to AmerisourceBergen Drug Corp for Paclitaxel Protein-Bound 100mg on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price contract has no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency's Medical Supply Chain issued a delivery order valued at $40,959.52 to AmerisourceBergen Drug Corp on September 8, 2025, with an ultimate completion date of September 9, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. AmerisourceBergen Drug...
- The U.S. Defense Logistics Agency's Medical Supply Chain issued a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, valued at $12,980.20 with an ultimate completion date of August 26, 2025. This competitive award, issued without set-aside designation, represents a firm fixed-price delivery order for pharmaceutical products and medical supplies. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE5Z8Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Docetaxel 80 mg/8 mL vials with a ceiling value of $1,314.60. This delivery order, issued on September 11, 2025, represents a firm fixed-price procurement executed without any set-aside designation, indicating competitive award to the contractor based on open competition. The product will be delivered to the Conshohocken, Pennsylvania location, with an ultimate completion date of September 12, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor headquartered in Pennsylvania, AmerisourceBergen serves as a critical federal vendor supplying comprehensive pharmaceutical products and medical supplies to military and veteran healthcare systems. The parent IDC enables the company to fulfill diverse medical procurement requirements across multiple therapeutic domains while supporting the Defense Health Agency and other government healthcare systems globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/11/25 |